baber/WOPTO huggingface dataset:
Patent FI-930798-A0 (FI)
Inventor: GRAY ANTONIO
IPC: G01K11/24
Filed: 1993-02-23
Abstract: PCT No. PCT/EP92/01244 Sec. 371 Date Feb. 5, 1993 Sec. 102(e) Date Feb. 5, 1993 PCT Filed Jun. 4, 1992 PCT Pub. No. WO93/00577 PCT Pub. Date Jan. 7, 1993.A system for measuring the "time of flight" or transfer time of a sound wave in a gas by using the relation between the gas temperature and the velocity of the sound wave in the gas, and calculating therefrom the temperature of the gas. The system comprises an emitter, which generates a sound which is coherent in phase, at one frequency or a group of frequencies; a self-correlating decoder and a receiver, which is associated with the emitter, and which sends the sound to a filter system and to an assembly controlled by a microprocessor, which processes the signal coming out of the filter system in a shape similar to a Hamming wave shape in order to determine the absolute maximum value and therefrom determine the transfer time. With this knowledge, it is easy to relate the transfer time to the distance traveled between the emitter and receiver and the known properties of the gas, in order to arrive at the temperature of the gas through which the sound has been sent.
Patent FI-973919-A0 (FI)
Inventor: LIPASTI LAURI
IPC: H03M7/00
Filed: 1997-10-09
Abstract: The invention relates to digital signal processing and specificly to level control of a pulse density modulated (PDM) signal generated by a sigma-delta modulator. A single-bit pulse density modulated PDM signal is generated by a first sigma-delta modulator (2) being an analog modulator, for instance. Level control is performed by multiplying the single-bit pulse density modulated PDM signal by a multibit multiplier (300) to obtain a multibit number stream, which is reconverted into a single-bit PDM signal by a second digital sigma-delta modulator (4). In accordance with the invention, the performance of the second sigma-delta modulator (4) is better than that of the first sigma-delta modulator (2), as to the signal-to-noise ratio. Thus, the most significant factor in the total signal-to-noise ratio (SNR) is the noise level of the first sigma-delta modulator (2), by which the PDM signal was originally generated. In the subsequent second sigma-delta modulator (4), the PDM signal can then be attenuated as much as is the difference between the SNR performances of the modulators without any decrease in the total signal-to-noise ratio. A relative amplification of the PDM signal is provided in this manner.
Patent FI-982028-A0 (FI)
Inventor: HURTTA TUIJA
IPC: H04W92/02
Filed: 1998-09-21
Abstract: A gateway support node (GGSN+HA) for a packet radio network, arranged to provide Internet Protocol, or IP, mobility for a mobile station (MS). The gateway support node (GGSN+HA) is interoperable with at least one home agent (HA) and at least one serving support node (SGSN), for routing data packets to/from the mobile station (MS). It comprises a protocol stack (18, 20) for supporting at least a layer 1 (L1) protocol, a layer 2 (L2) protocol, and a network layer (L3) protocol, the network layer (L3) protocol supporting at least IP protocol. It also comprises the functions of the home agent (HA) and it is arranged to support Mobile IP protocol on the network layer (L3). Preferably, the protocol stack (20) is streamlined by routing data packets to/from the integrated home agent/gateway node (GGSN+HA) using only the network layer (L3) protocol and the layer 2 and layer 1 protocols.
Patent AP-9901469-A0 (AP)
Title: Protein kinases and uses thereof.
Inventor: LUSSO MARCOS
IPC: C12N5/10
Filed: 1998-07-07
Abstract: Nucleic acid molecules are disclosed that are induced upon pathogen invasion or elicitor treatment. Such molecules aree functional in plants, plant tissue and in plant cells for inducible gene expression and altering the diseasee resistance phenotype of plants. Such molecules are, or are related to, sequences of calcium dependent protein kinase genes. Also diclosed are methods for obtaining transgenic plants containing such nucleic acid molecules and methods for using such molecules. Polypeptides encoded by such nucleic acids are also diclosed herein.
Patent IL-61818-A0 (IL)
Title: Preparation of polycyclic nitrogen-containing compounds
IPC: C07D249/00
Filed: 1980-12-29
Abstract: A process for the preparation of polycyclic nitrogen-containing compounds of the formula   <IMAGE>   where R is hydrogen or an organic radical, wherein a compound of the formula   <IMAGE>  where Alk is alkyl of 1 to 4 carbon atoms and R has the above meanings, is reacted with a solution of an alkali metal hydroxide or of calcium hydroxide and the product is then oxidized.
Patent IL-79065-A0 (IL)
Title: Process for the preparation of meldrum's acid
IPC: C07D319/06
Filed: 1986-06-09
Abstract: A process for producing Meldrum's acid in excellent yield is disclosed wherein acetic anhydride is added in a slow, controlled manner to a mixture of acetone, malonic acid and an acid catalyst.
Patent IL-83183-A0 (IL)
Title: Immunotoxins,their preparation and pharmaceutical compositions containing them
IPC: C07K16/00
Filed: 1987-07-14
Abstract: New immunotoxins obtained by covalent coupling between, on the one hand, trichosantine or trichokirine as such or appropriately modified and, on the other hand, an antibody or antibody fragment, employed in its natural or correctly modified form, the said coupling being produced either through the intermediacy of a disulphide bond or through the intermediacy of a thioether bond. 
<??>The invention also relates to a process for the preparation of the said immunotoxins and to pharmaceutical compositions containing them as an active substance.
Patent IL-85874-A0 (IL)
Title: Low power digital receiver
IPC: H03J5/02
Filed: 1988-03-25
Abstract: A low power digital receiver (10) is provided that contemporaneously selects the lowest possible sampling signal frequency (34) (from a plurality of available sampling signals), and received signal level (28) to properly digitize (32) and recover a desired signal. Digitization is performed after the first IF using broadband stages (28, 30, and 32) that are temporarily enabled (44) to rapidly digitize the first IF signal. This, together with the low sampling rate, minimizes the power consumption of the receiver (10) thereby permitting portable and mobile digital receiver embodiments.
Patent IL-93315-A0 (IL)
Title: Medicaments having controlled release of the active compound comprising pyridine derivatives
IPC: A61K9/54
Filed: 1990-02-08
Abstract: The invention relates to an active ingredient delivery system in pellet form, with which the release of active ingredient can be adjusted in a time-controlled manner, in pulsed form, as well as in its gradient in each case. The pellets consist of a core which contains active ingredient and is enveloped in a polymer-containing coating and an indigestible water-permeable lacquer layer. 
<IMAGE>
Patent IL-94128-A0 (IL)
Title: Production of vascular endothelial cell growth factor and dna encoding same
IPC: A61K38/00
Filed: 1990-04-19
Abstract: DNA isolates coding for a vascular endothelial cell growth factor may be used to produce the protein via recombinant expression systems. Such protein is useful therapeutically to treat conditions in which a selective action on the vascular endothelial cells, in the absence of excessive connective tissue proliferation, is desirable.
Patent IL-96073-A0 (IL)
Title: Thermoplastic elastomer of propylene polymer material and crosslinked ethylene-propylene rubber and its production
IPC: C08K3/22
Filed: 1990-10-22
Abstract: Disclosed is a dynamically partially cured thermoplastic elastomer comprising a propylene polymer material, an amorphous ethylene-propylene copolymer rubber, a semi-crystalline, low density, essentially linear ethylene-propylene copolymer and a curing system containing 1,2-polybutadiene and an organic peroxide and a method of making the same.
Patent AU-PR256401-A0 (AU)
Title: An apparatus (AP17)
IPC: B41J3/42
Filed: 2001-01-17
Abstract: Provided is a hand held personal digital assistant (PDA). The PDA includes body and display sections interconnected via a hinge section, as well as an internal printer arranged in the body section. The internal printer includes a printhead, a motor driver and media transport device arrangement for transporting print media from a roll of print media past the printhead, and a motor driver and guillotine motor arrangement for severing the printed print media from the roll of media. Also included is a microcontroller for controlling the printhead and respective motor driver arrangements.
Patent FI-20021145-A0 (FI)
Inventor: VAERRI ALPO
IPC: A61B5/11
Filed: 2002-06-13
Abstract: The invention relates to an apparatus for measuring the vital functions of a patient, which apparatus comprises at least a measuring chair (20) or a corresponding means suitable for sitting, which measuring chair further comprises one or more measuring sensors (2, 3, 6, 7) for measuring one or more vital functions of the patient sitting in the measuring chair, in a non-invasive manner from the outside of the patient's body. According to the invention, said one or more measuring sensors (2, 3, 6, 7) are placed in the structures of the measuring chair (20) in a substantially unnoticeable way, and the measuring chair (20) is preferably designed to resemble an ordinary chair intended for non-medical use, or a corresponding furniture-like means suitable for sitting. By means of the invention, it is possible to reduce the distortion caused by fear of doctors in the measurement results. The invention is particularly suitable, for example, for ballistocardiographic measurements and/or measurements relating to pulmonary functions.
Patent FI-20115343-A0 (FI)
Inventor: JAY DAVID
IPC: F02M/
Filed: 2011-04-12
Abstract: The invention relates to a fuel injection system (10) comprising a fuel injector(16) having a fuel admission section (18) arranged to controllably introduce fuel from the fuel injector, a pressure accumulator (24) in the fuel injector arranged in flow connection with the admission section and a fuel inlet (26) arranged in flow connection with the pressure accumulator, which fuel injection system is provided with at least one heat exchanger system (100). The at least one heat exchanger system (100) arranged to effect on the pressure accumulator (24) of the fuel injection system from outside thereof. The present invention relates also to a method of regulating temperature of at least one fuel injector, cylinder head and a combination of a cylinder head and a fuel injection system.
Patent IL-104984-A0 (IL)
Title: Anti-tumour compounds
Inventor: PEGG STEPHEN JOHN
IPC: A61P35/00
Filed: 1993-03-08
Abstract: The invention relates to quinazoline derivatives, or pharmaceutically-acceptable salts thereof, which possess anti-tumour activity; to processes for their manufacture; and to pharmaceutical compositions containing them. The invention provides a quinazoline of the formula:- <CHEM>  wherein R<1> is (1-4C)alkyl; the quinazoline ring may optionally bear one or two further substituents selected from halogeno, (1-4C)alkyl and (1-4C)alkoxy;  R<2> is hydrogen or (1-4C)alkyl;  R<3> includes hydrogen and (1-4C)alkyl; and  Ar is optionally substituted phenylene or heterocyclene; or a pharmaceutically-acceptable salt or ester thereof.
Patent IL-113783-A0 (IL)
Title: Microbicidal compositions and their use
IPC: A01C1/00
Filed: 1995-05-18
Abstract: Plant microbiocidal agent (A) comprises synergistic amounts of at least two components from compound (I), chosen from tetraconazole (Ia) or bromuconazole (Ib), and cyprodinil (II), in a carrier. All components may be present as their salts or metal complexes.  An Independent claim is also included for plant replicative material treated with (A).
Patent IL-114642-A0 (IL)
Title: Pharmaceutical compositions containing cefaclor
IPC: A61K47/32
Filed: 1995-07-18
Abstract: Pharmaceutical formulations of cefaclor, suitable for the direct-compression manufacture of dispersible tablets, containing the antibiotic cefaclor in an amount between 35% and 50% by weight of the total weight of the formulation, along with suitable excipients and coadjuvants selected from disintegrators, diluents, lubricants, antiadherents, sweeteners, fragrances and, optionally, flavorings, opacifiers and colorants. Said formulations are suitable for the manufacture of dispersible tablets which disintegrate in less than three minutes in water at 19° - 21°C, and are suitable for the treatment of infections caused by bacteria strains sensitive to cefaclor.
Patent IL-121350-A0 (IL)
Title: Multimetallic catalyst and process for preparing substituted aromatic amines
IPC: C07C211/45
Filed: 1997-07-21
Abstract: Multi-metal catalyst containing iridium and at least one doping element on a support uses at least one element chosen from manganese, cobalt, iron, nickel, copper or ruthenium as the doping agent for iridium. The preparation of substituted aromatic amines by hydrogenating the corresponding substituted aromatic nitro compounds in the presence of the above catalyst is also claimed.
Patent IL-121913-A0 (IL)
Title: Glial derived neurotrophic factor
IPC: C12N5/10
Filed: 1997-10-07
Abstract: A novel neurotrophic factor referred to as glial derived neurotrophic factor (GDNF) has been identified and isolated from serum free growth conditioned medium of B49 glioblastoma cells. Rat and human genes encoding GDNF have been cloned and sequenced. A gene enconding GDNF has been subcloned into a vector, and the vector has been used to transform a host cell in order to produce biologically active GDNF in a recombinant DNA process. <IMAGE>
Patent IL-125010-A0 (IL)
Title: Procedure and system for the setting up of calls
IPC: H04Q3/00
Filed: 1996-12-17
Abstract: A procedure and system for setting rates between two predetermined subscriptions in a telephone network without the necessity of substantial system changes to the telephone network. Calls between two predetermined subscriptions can be rated according to a special tariff and changes can be easily and flexibly included in the normal invoicing. When the number of subscriptions per customer is limited to two, the common call number for all customers is the same, e.g. 020100. When this number is dialed, the call is directed to the wired network subscription specified in the subscriber number pair, which is stored in a database, when the call is made from a mobile station, and vice versa. When the number of subscriptions connected to the system by the customer is greater than two, the common call number comprises a prefix part which is the same for all customers and on the basis of which the telephone network exchange recognizes the service call of intelligent network calls and specially rated calls, and a suffix part which is an integer and which, via the intelligent network, determines the desired individual subscription among subscriptions selected to be included in the system by the customer.
Patent IL-126797-A0 (IL)
Title: Polydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
IPC: C07C45/00
Filed: 1997-05-14
Abstract: Compounds useful as preventive and therapeutic agents for bone and cartilage diseases; and drug compositions containing the same. The compounds are polyhydroxyphenol derivatives of general formula (I) and quinone analogues derivative therefrom <CHEM> (wherein R1 is alkyl, optionally substituted benzyl, or optionally substituted aryl; R2 is hydrogen, alkyl, alkenyl or optionally substituted benzyl; R3 is hydrogen, alkyl, alkenyl, optionally substituted benzyl, hydroxyl, alkoxy. alkenyloxy or optionally substituted benzyloxy; R4 is hydrogen, alkyl, alkenyl, optionally substituted benzyl or hydroxyl; and R5 and R6 are each independently hydrogen, alkyl, alkenyl or optionally substituted benzyl). The polyhydroxyphenol derivatives and quinone analogues exhibit a potent inhibitory activity against bone resorption and are useful as preventive and therapeutic agents for bone and cartilage deseases.
Patent IL-132433-A0 (IL)
Title: Contrast agent preparation
IPC: A61K49/04
Filed: 1998-04-07
Abstract: In the metallation of complexing agents such as DTPA-BMA with a lanthanide using a lanthanide oxide such as the lanthanide source, oxalic acid is used as a reaction accelerator.
Patent IL-139424-A0 (IL)
Title: Disposable absorbent article
IPC: A61F13/15
Filed: 1999-05-24
Abstract: A disposable garment of the type of worn about the torso of a wearer is disclosed. The garment has a front region, a back region, a crotch region between the front region and the back region, a waist opening, and leg openings. The garment has a zone of extensibility comprising a side elastomeric material and a waist elastomeric material. When the garment is applied to a standard mannequin, the skin contact pressure of the side elastomeric material and the waist elastomeric material pressing on the skin of the standard mannequin is not greater than 0.75 psi.
Patent IL-153258-A0 (IL)
Title: Self-driven projectile with a penetrator core
IPC: F42B12/06
Filed: 2001-06-18
Abstract: A self-propelled projectile comprises a penetrating core (1) that contains explosive material (4,3a). A hollow chamber (2) coaxial to the core contains a non-lethal substance. If the core is placed in a ballistic weapon, the same non-ballistic conditions as those of conventional weapons can be controlled so the drives, platforms and logistics can be used. The projectile can contain tear gas.
Patent IL-159934-A0 (IL)
Title: Rod and connector toy construction set
IPC: A63H33/08
Filed: 2002-12-16
Abstract: A rod and connector toy construction set, especially for use by young children. Connector elements, are formed with one or more rod-gripping sockets arranged radially with respect to a hub. The sockets are open at opposite sides, enabling lateral insertion and removal of rods. The connector elements, which are relatively large for easy handling by small children, are formed of a soft and pliant plastic material, to facilitate assembly and disassembly of rods with the connector elements by small hands. The rods generally are formed of a plastic material harder and stiffer than the connector material to accommodate easy handling of the rods during assembly and disassembly and to provide adequate strength in an assembled structure. The rods include enlarged, generally cylindrical end portions and adjacent neck portions of reduced diameter. The connector sockets include inner portions, configured to receive and closely confine the rod end portions, and outer portions arranged to receive and snuggly grip the rod neck portions, such that rods are held in axial alignment with the connector sockets.
Patent IL-162874-A0 (IL)
Title: Amino alcohol and phosphonic acid derivatives and pharmaceutical compositions containing the same
IPC: A61P17/04
Filed: 2003-01-09
Abstract: Aminoalcohol derivatives (I) are new. Aminoalcohol derivatives of formula (I) and their salts and esters are new. [Image] R 1, R 2H, lower alkyl or amino protecting group; R 3H, lower alkyl or hydroxy protecting group; R 4lower alkyl; n : 1-6; X : O or ND; D : H, Ar, SO 2-lower alkyl, SO 2Ar or A; Y : ethylene, vinylene, ethynylene, ECH 2 or 6-10C arylene (optionally substituted by 1-3 A); E : CO or CHOH; Z : bond or 1-10C alkylene optionally substituted by 1-3 A or B and optionally interrupted by O or S; R 5H, 3-10C cycloalkyl, Ar or 5-7 membered heterocyclyl containing 1-3 O, N and/or S all optionally substituted by 1-3 A or B; R 6, R 7H or A; A : halo, lower alkyl, lower haloalkyl, O-lower alkyl, S-lower alkyl, COOH, COO-lower alkyl, OH, lower aliphatic acyl, NH 2, NH-lower alkyl, N(lower alkyl) 2, lower aliphatic acylamino, CN or NO 2; and B : 3-10C cycloalkyl, Ar or 5-7 membered heterocyclyl containing 1-3 O, N and/or S all optionally substituted by 1-3 A; provided that when R 5 = H then Z is not a bond or linear 1-10C alkylene. ACTIVITY : Immunosuppressive; Dermatological; Antiarthritic; Antirheumatic; Antiinflammatory; Osteopathic; Vasotropic; Gastrointestinal-Gen.; Antiulcer; Hepatotropic; Cardiovascular-Gen.; Respiratory-Gen.; Antiasthmatic; Cardiant; Nephrotropic; Hypotensive; Neuroprotective; Antidiabetic; Antiarteriosclerotic; Muscular-Gen.; Virucide; Antianginal; Antiaggregant; Thrombolytic; CNS-Gen.; Nootropic; Antiparkinsonian; Antidepressant; Anticonvulsant; Cytostatic; Uropathic; Ophthalmological. In a graft versus host reaction model using Lewis and WKAH/Hkm rats administration of 2-amino-2-methyl-5-[5-(5-phenylpentanoyl)thien-2-yl]butan-1-ol (Ia) maleic acid salt (0.008 mg/kg/day p.o.) inhibited host versus graft reaction by 16.0 %. The corresponding value for a combination of (Ia) maleic acid salt (0.008 mg/kg/day p.o.) and cyclosporin A (0.08 mg/kg/day p.o.) was 36.1 % and for cyclosporin A (0.08 mg/kg/day p.o.) was 18.7 %. MECHANISM OF ACTION : Synergist.
Patent IL-166657-A0 (IL)
Title: Pharmaceutical compositions containing an agent effective to reduce the effective amount of clusterin
IPC: A61K38/00
Filed: 2005-02-02
Abstract: Treatment of melanoma is achieved through reduction in the effective amount of clusterin in melanoma cells of in a mammalian subject, preferably a human. A therapeutic agent effective to reduce the effective amount of clusterin in the melanoma cells is administered to the subject. The therapeutic agent may be, for example, an antisense ODN or small inhibitory RNA (siRNA) compound targeted to clusterin. bcl-xL in a subject or cell line can also be regulated by administering to the subject or cell line an agent effective to modulate the amount of clusterin expression. In particular, in clusterin expressing cells, the expression of bcl-xL is down-regulated when the effective amount of clusterin is reduced. Such inhibition is significant because bcl-xL is known to act as an inhibitor of apoptosis.
Patent IL-172748-A0 (IL)
Title: Ad hoc COMMUNICATION SYSTEM AND METHOD OF R ROUTING SPEECH PACKEST THEREIN
Filed: 2005-12-22
Abstract: A method for organizing a plurality of communication devices of an ad hoc communication system into a communication network. The devices are organized into one or more communication graphs where at least one of the graphs is a rooted tree. The invention also provides an ad hoc communication system wherein the devices are organized into one or more communication graphs, where at least one of the graphs is a rooted tree. A method for routing a communication session in the system is also provided where a session is routed from the calling node to the tree root and from the tree root to the called node. In a preferred embodiment, shortcuts are sought in the session route.
Patent IL-173801-A0 (IL)
Title: System for detecting and locating faults in an electric fence
IPC: G01R31/50
Filed: 2006-02-19
Abstract: The invention relates to a system for detecting faults (1) in an electric fence. The inventive device comprises: a capacitor (C1) which can be connected to a conductor wire (31) belonging to the fence; a generator (42) which applies high-voltage pulses to the capacitor in order to give an electric shock to anyone touching the wire; a fault-detection sinusoidal-signal generator (41) which applies said signals to the capacitor; a device for measuring the voltages at the terminals of the capacitor (C1); and a measurement-processing device which determines (i) if the fault is a short circuit or a failure on the connected wire, and (ii) the distance between said fault and the capacitor (C1).
Patent IL-174868-A0 (IL)
Title: Preparation of candesartan cilexetil
IPC: C07D403/10
Filed: 2006-04-09
Abstract: The invention encompasses processes for the synthesis of cilexetil trityl candesartan from the reaction of trityl candesartan with cilexetil halide in the presence of a base and a low boiling organic solvent. Optionally, the reaction may be conducted in the presence of a phase transfer catalyst.